Poszukujemy zorientowanego na misję Business Development Managera, który będzie prowadził sprzedaż naszego rozwiązania na polskim rynku, jeśli do tego lubisz pracę w startupowej atmosferze, to jest to miejsce dla Ciebie. CliniNote to dynamiczny startup, w którym wykorzystujemy uczenie maszynowe (machine learning), sztuczną inteligencję (AI) oraz przetwarzanie języka naturalnego (NLP) do pracy na danych rzeczywistych (Real World Data).
Nasz zespół, doradcy i inwestorzy wyznają takie wartości jak uczciwość, otwartość, wzajemne wsparcie, skupienie i konsekwencja w dążeniu do celów.
Bądź wśród pierwszych, dołącz do nas i zmieniaj świat na lepszy!
Business Development Manager
PRACA : zdalna lub hybrydowa / biuro WARSZAWA
ZAKRES ODPOWIEDZIALNOŚCI:
WYMAGANIA:
Będziesz jeszcze bliżej CliniNote jeśli posiadasz:
OFERUJEMY:
CV prosimy przesyłać na adres: jobs@clininote.com
Five international healthtech startups have made it to the final phase of DayOne Health 4.0. With this accelerator, DayOne, the initiative of Basel Area Business & Innovation, aims to promote solutions that focus on artificial intelligence, data and clinical development.
The selection committee has chosen five healthtech startups for the second and final phase of the six-month DayOne Health 4.0 accelerator programme: Briya from Israel, CliniNote from Poland, FindMeCure from Bulgaria, InSilicoTrials Technologies from Italy and machineMD from Switzerland. DayOne is an initiative of Basel Area Business & Innovation, the investment and innovation promotion agency. It is doing pioneering work for the future of healthcare.
The thematic focus of this edition of the accelerator, which began in September 2023 and ends in March 2024, is artificial intelligence (AI), data and digitally improved clinical development. It received a total of 109 applications from 35 countries. Fifteen of the applications had passed Phase 1 by mid-November. According to the jury, the five projects that have now been selected offer a strong value proposition, made significant progress in phase 1 of the programme, and are ready to engage in collaborations, particularly with biopharmaceutical companies.
During the final gala held on December 7, 2023, at the Museum of Polish Jews, the winners of the competition organized by the Mother and Child Health Institute - Mother and Child Startup Challenge were announced. Among the awarded startups was CliniNote.
"On behalf of the entire CliniNote team, we sincerely thank the competition jury for this recognition. Being among such a select group is an acknowledgment of what we do every day, and most importantly, supporting healthcare - assisting doctors in their daily work and patients. Thank you for this solid dose of motivation; it will allow us to develop CliniNote technology even more intensively," said Bogdan Marszałek, Product Owner of CliniNote, who represented our team during the event.
The Mother and Child Startup Challenge is the first project of its kind on a Polish scale and one of the few in Europe bringing together state medical entities for a common purpose – harnessing the potential of medical technology and innovations aimed at health and life protection. The initiator of the competition is the Mother and Child Institute. Representatives of leading institutions in healthcare, medical universities, and technological fields sit on the Program Board and the Competition Jury.
Last week we proudly participated in the annual Connect to Win meeting in Madrid. As a key contributor to the DigiOne international project led by the Digital Institute for Cancer Outcomes Research, we engaged in discussions on leveraging technology to support Research and Development (R&D) initiatives in the field of oncology.
Our Chief Technology Officer, Jan Poleszczuk, took the stage with vigor to present the groundbreaking topic, "AI-Augmented Virtual Assistant for Better Data Capture." Jan's central message resonated deeply: "Medical staff's time is particularly valuable. Our mission is to solve the long-standing dilemma of the need to gather an increasing amount of data while striving to free up time for healthcare professionals and medical staff to work with patients. Today we can prove it with results of projects delivered. We are convinced that our solution will also contribute to solving the problem of interoperability, which means connecting data from various healthcare providers regardless of languages and infrastructure challenges, thus speeding up research in medicine, which is a goal of the DigiOne project."
Partnership with IQVIA
In line with the objectives of the DigiOne project, we are thrilled to announce a strategic partnership between IQVIA and CliniNote in the realm of data collection products. The collaboration involves integrating IQVIA's Natural Language Processing (NLP) software, designed to facilitate retrospective medical record data, with CliniNote's solution supporting prospective clinical data collection.
The integration of IQVIA's NLP software with CliniNote's platform is poised to revolutionize the way healthcare professionals and the pharmaceutical industry work with clinical data. By co-developing these solutions, we aim to not only streamline data collection processes but also enhance the quality and availability of data for medical research.
CliniNote has signed an agreement with Novartis to implement a digital solution for oncology hospitals. The first hospital to engage in the venture and define the assumptions of the pioneering solution is the M. Kopernik Regional Multispecialty Center for Oncology and Traumatology (WWCOiT) in Lodz.
The cooperation is to relies on the implementation of the CliniNote system, which makes it possible to structure medical notes in terms of data for calculating evaluation metrics and monitoring key indicators of the quality of care for breast cancer patients at WWCOiT.
Reporting of the above indicators is a requirement defined within the guidelines for the centers of the National Oncology Network established as part of the National Oncology Strategy, whose goal is particularly to improve standards of care for cancer patients. With the support of partners, WWCOiT has initiated preparations for reporting metrics and conducted tests in hospital conditions. The agreement signed between WWCOiT, Novartis, and CliniNote is part of a broader program aimed at improving standards of care for breast cancer patients, involving the gradual inclusion of additional centers.
Novartis Poland will be responsible for overall coordination of the effort.
- CliniNote's technology allows the company to work with clinical data in real time, identifying and appropriately recording data as soon as it is created - prospectively. Information can be accessed as soon as the medical note is saved, making the flow of data easier and faster while saving doctors' time. Thanks to this innovation, our clients gain the possibility to obtain real-world data, so called real-world data, previously very difficult to access, and increase efficiency, e.g. automating data entry into eCRF in clinical trials or feeding registries or other systems, which today unnecessarily absorbs medical staff,"- says Robert Lugowski, CEO of CliniNote
Entering and analyzing medical data on a patient will no longer require spending a lot of time. The product is expected to enable the collection of structured information, as well as facilitate the work of doctors and medical personnel in creating medical documents and notes. The collected data can not only be used to calculate metrics, it is a valuable resource for scientific work, the development of new diagnostic methods and therapies, or work in the development of digital medicine, including artificial intelligence algorithms.
- We are very excited about the prospect of working with Novartis and CliniNote. When human lives are at stake, time and precision are of the utmost importance. New technologies, as in the case of CliniNote, will certainly make it possible to speed up and automate many processes. This will allow oncologists to focus on what is most important, which is working with patients, and the Center will have a structured database necessary to measure and monitor indicators of the quality of patient care. - says Magdalena Janus- Hibner, Deputy Director for Oncology Development and Organization Projects of the M. Kopernik Regional Multispecialty Oncology and Traumatology Center in Lodz.
🎙Our CEO Rafal Szmuc presented the CliniNote ecosystem and how it changes the way we work with healthcare data during the conference Venture Network Day @Warsaw Stock Exchange - a conference that puts emphasis on synergy between the electronic stock exchange ecosystem and selected startups. GPW Venture Network Day is a space for exchanging ideas and experience with leading specialists in the field, technology and innovation.
PRESS RELEASE
CliniNote: Pioneering a Paradigm Shift in Healthcare Data
CliniNote, a Poland-based startup, is embarking on a transformative journey within the healthcare data industry. Created by a robust team of industry veterans and with its first institutional investment, CliniNote is poised to reshape how healthcare professionals work with clinical data.
CliniNote is addressing the challenges associated with collecting and processing clinical data, as crucial step for the seamless integration of Artificial Intelligence (AI) and Natural Language Processing (NLP) into healthcare workflows. This forward-looking approach involves transforming established practices and elevating efficiency to new heights.
The CliniNote Assistant empowers medical personnel by simplifying clinical documentation processes while effortlessly capturing comprehensive real-world data via a software plugin. This innovative approach enhances the efficiency of medical documentation preparation and enables the creation of a database of Real-World Data, previously considered unattainable, without placing additional burdens on doctors, altering existing processes, or requiring a dedicated integration with hospital information systems.
CliniNote's technology extends beyond clinical documentation, offering increased efficiency in various data processes within healthcare and pharmaceutical domains like the acceleration of clinical trials, a critical process.
"It’s our mission to resolve the enduring dilemma of balancing the need to save doctors' time with the imperative to collect more clinical data, which is crucial for the transformation of the healthcare industry. We firmly believe that our solution also effectively addresses the pressing issue of interoperability in the healthcare industry" Robert Lugowski, CEO of CliniNote, commented.
CliniNote has successfully closed tit’s initial financing round, led by CEE focused early stage VC Sunfish Partners with additional support from business angels including Katarzyna Pieniądz, Pawel Mańdok, Pawel Woźniak, Piotr Ruciński and Winicjusz Filipow among others. CliniNote remains open to further investment opportunities and is gearing up to conclude the second part of the round in November. “We decided to back CliniNote as we believe in the enormous opportunity in this area ahead of the introduction of the European Health Data Space. Making unstructured treatment data usable for data exchange and applications in artificial intelligence is one of the most pressing challenges in digital healthcare. In CliniNote we found an extraordinary team with a bold vision and first implementations and partnerships tackling this very problem.” says Max Moldenhauer, Managing Partner of Sunfish Partners.
CliniNote remains open to further investment opportunities and is gearing up to conclude the second part of the round in Q4 2023.
For media inquiries and investment opportunities, please contact: press@clininote.com
About CliniNote:
CliniNote is a health-tech startup headquartered in Warsaw, Poland. It specializes in clinical AI and NLP solutions. It’s flagship product, the CliniNote Assistant, is revolutionizing how healthcare professionals interact with clinical data. Their innovative technology empowers doctors and medical staff to effortlessly collect vital clinical data without disrupting existing healthcare processes. CliniNote was founded in 2020 and currently employs 12 people.
About Sunfish Partners:
Sunfish Partners is an early-stage venture capital fund investing in outstanding tech-forward companies in Central and Eastern Europe. Sunfish has invested in 14 companies so far, including some of the most innovative companies in digital health in CEE like Molecule.one, Aether Biomedical, and Solvemed.ai. Sunfish Partners in based in Berlin and Warsaw and is managed by Dr. Marcus Erken, Max Moldenhauer, and Pawel Lipkowski.
CliniNote is thrilled to share some exciting news! 🚀 We're privileged to have been selected for the DayOne - Healthcare Innovation accelerator in Basel, the European capital of the pharmaceutical industry.
Our journey began with two incredible days of workshops as part of the #DayOneHealth40 accelerator kick-off. Meeting experienced mentors, learning from industry veterans, and networking with fellow founders to exchange ideas were the highlights of this enriching program. The spirit of optimism was truly infectious!
We're eagerly looking forward to the next two months of collaborative events and seizing every opportunity in the pharmaceutical realm. Stay tuned for more updates as we embark on this exciting adventure! 💪💊🌟
Follow on our LinkedIn: https://www.linkedin.com/posts/clininote_dayonehealth40-clininote-dayone-activity-7108789204741947392-csuJ
We're #hiring a new Business Development Manager in Warsaw, Mazowieckie.
Click here for more: Business Development Manager
We’re #hiring a new Product Manager in Warsaw, Mazowieckie.
Click here for more: Product Manager
